Charles River To Acquire Vigene Biosciences For $292.5 Mln In Cash - Quick Facts

(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Monday that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene delivery solutions. The addition of Vigene Biosciences' extensive gene therapy expertise will enable...